FRCS Revision

This site is private

Enter the password to open the revision library.

Personal revision library · not clinical advice
FRCSRevision
Home / Statistics / Soft tissue and neural tumour cases
Statistics

Soft tissue and neural tumour cases

Soft tissue tumour, nerve tumour and skin lesion cases including liposarcoma and melanoma.

37 questions 6 source pages

Images appear with the first question taken from each source page — tap a question to open it.

37 questions
Q1Describe the clinical photo and how you assess the mass.▸
  • Large swelling over the left back with some overlying skin bruises
  • Assess for inflammation, nature of mass (consistency), position and attachment, regional lymph nodes
  • Large soft intramuscular swelling
Q2What features suggest malignancy in a soft tissue tumour?▸
  • >5cm, deep to fascia
  • Progressive in size, onset of pain
Q3How are soft tissue sarcomas classified and staged?▸
  • AJCC: 1. size (>5cm), 2. deep to fascia, 3. node, 4. metastasis, 5. grade
  • Stage 1 = low grade, 2 = high grade, 3 = deep to fascia, 4 = metastasis
  • Grading: low (well differentiated), intermediate (myxoid), high (de-differentiated)
  • Stage 1-2: 80% 5-year survival; stage 3-4: 50% 5-year survival
Q4How would you investigate a suspected soft tissue sarcoma?▸
  • X-ray to see bony destruction
  • MRI: extent, invasion, NV involvement (increase T2, decrease T1; gadolinium - increased T1 peripherally, decreased centrally in cystic/necrotic areas)
  • Bloods to rule out infection and check INR
  • Image-guided biopsy (histology + MDM2 genetic marker)
  • At least CT thorax to rule out metastasis
Q5What is the management and when is pre-operative radiotherapy given?▸
  • Wide local excision +/- radiotherapy
  • May consider marginal excision in low grade (well-differentiated liposarcoma)
  • Pre-op RT depends on histological grade, cell type (myxoid), and proximity to NV bundle
  • Myxoid type: CT TAP for abnormal sites of metastasis; preop radiotherapy as vascular
Q6What are the features of MFH, synovial sarcoma and liposarcoma?▸
  • MFH (= undifferentiated pleomorphic sarcoma): most common soft tissue sarcoma; slow growing, no ecchymosis, lung mets; iso T1, increased T2; pleomorphic (>80%) > giant cell (10%) >infl (<10%), most high grade
  • Synovial sarcoma: not synovial origin; commonest sarcoma in young adults (15-40) in the foot; LN and lung mets; calcification 25%; gene (X;18); biphasic epithelial + spindle cells; always high grade
  • Liposarcoma: 2nd most common soft tissue sarcoma, not from lipoma; lipoblasts; types well differentiated/sclerosing/myxoid; high grade round cell/pleomorphic/dedifferentiated
Q7What is a neurilemmoma and what are its histological features?▸
  • Benign schwannoma
  • Antoni A: spindle cells in intersecting bundles (battle formation); Antoni B: less cellular, loosely arranged cells
  • Verocay bodies: pathognomonic - two rows of aligned nuclei in palisading formation
  • S100 positive; MRI string sign; paraesthesia in distribution of the peripheral nerve
Q8What is the treatment of neurilemmoma?▸
  • Observe
  • Excision carries a high rate of sensory deficit
  • Careful dissection, excise lesion parallel to nerve fascicles
Q9How do neurofibroma and schwannoma differ in relation to nerve fibres?▸
  • Schwannoma is eccentric to nerve fibres
  • Solitary neurofibroma is central to nerve fibres
  • Neurofibroma involves non-myelinating Schwann cells and other perineural cells
  • Excision with nerve graft if symptomatic
Q10Compare NF type I and type II.▸
  • Type I (von Recklinghausen): chromosome 17, tibia pseudoarthrosis, spine most common skeletal involvement - dystrophic scoliosis and dural ectasia
  • Type II: chromosome 22, bilateral vestibular schwannoma, central meningioma, no scoliosis
  • Autosomal dominant disorder of neural crest
  • Skeletal: scoliosis, kyphosis, atlantoaxial instability; congenital anterolateral bowing of tibia/forearm; hemi-hypertrophy
Q11Compare dermal and plexiform neurofibromas.▸
  • Dermal: single peripheral nerve, fusiform swelling; 90% sporadic, 10% in NF1; at puberty; do not become malignant
  • Plexiform: multiple nerve bundles, bag of worms; pathognomonic of NF1; early childhood; 10% become malignant (MPNST)
Q12What is MPNST and neuroblastoma?▸
  • MPNST (malignant schwannoma): arises from large nerves (sciatic, brachial plexus), motor and sensory deficit; treat with wide surgical resection + radiotherapy
  • Neuroblastoma: malignant from sympathetic neural tissue; most common solid tumour of childhood
  • Adrenal involvement causes tachycardia and abdominal mass; bone mets common and poor prognostic; lecturer describes overall good prognosis
  • Treatment: chemo + stem cell transplant + surgical excision
Q13What are the types of Schwann cells and their significance?▸
  • Myelinating Schwann cells - found in large nerves
  • Non-myelinating Schwann cells - found in small nerves, responsible for neurofibromatosis
Q14What is an intramuscular myxoma?▸
  • Benign, homogeneous
  • Excise if symptomatic
  • MRI: bright T2, dark T1
Q15What is rhabdomyosarcoma?▸
  • Malignant; most common soft tissue sarcoma in children
  • Rapidly growing painless mass
  • Treatment: chemo for metastasis, radiotherapy for inoperable, excision
Q16What is leiomyosarcoma?▸
  • Aggressive malignant tumour from smooth muscle cells lining small blood vessels
  • Osteolytic, moth-eaten lesions in the metaphysis of long bones
  • Treatment: chemotherapy + wide surgical resection
Q17What is dermatofibrosarcoma protuberans?▸
  • Fibrogenic cutaneous sarcoma
  • Can result from neurofibromatosis
  • t(17;22) encodes PDGFB/COL1A1 fusion protein
Q18What is malignant fibrous histiocytoma (undifferentiated pleomorphic sarcoma)?▸
  • Most common soft tissue sarcoma in adults
  • Pain and swelling; high grade - looks like osteosarcoma
  • Types: pleomorphic 80-85%, giant cell 10%, inflammatory <10%
  • Treatment: same as osteosarcoma - wide local resection and radiation
Q19What is extra-abdominal desmoid tumour and its associations?▸
  • Aggressive fibromatosis; most invasive of benign soft tissue tumours
  • Associations: Dupuytren's disease, Ledderhose disease, FAP
  • Distinctive rock hard mass; oestrogen receptor positive
  • Treatment: tamoxifen (oestrogen receptor blocker) and radiotherapy
Q20What is nodular fasciitis?▸
  • A reactive lesion
Q21What is plantar fibromatosis (Ledderhose disease)?▸
  • Myofibroblast and collagen proliferation
  • Similar process to Dupuytren's fibromatosis
  • Ask about hand involvement and Peyronie's disease in men
Q22What is calcifying aponeurotic fibroma?▸
  • Painless mass in the hands and feet of children and young adults
Q23What is a glomus tumour and where does it occur?▸
  • Benign subungual tumour arising from the glomus body, a perivascular temperature-regulating structure
  • Frequently at the tip of a digit or beneath the nail
  • Usually young adults 20-40 years; 3/4 in hand, 1/2 in finger, 1/2 with distal phalanx erosion
  • Ddx: melanoma
Q24What is the classic clinical triad of a glomus tumour?▸
  • Paroxysmal pain
  • Exquisite tenderness to touch
  • Cold intolerance
Q25What are the Love and Hildreth tests?▸
  • Love test: pinhead -> pain
  • Hildreth test: tourniquet -> less pain
Q26What imaging and treatment are used for a glomus tumour?▸
  • X-ray: pressure erosion; MRI: low T1, high T2
  • Marginal excision +/- reconstruct nailbed contour with autogenous fat graft
  • Recurrence 20%
Q27Describe the clinical findings in this patient with a glomus tumour.▸
  • Partial bluish discoloration of the nail
  • No nail ridging
  • Ddx: melanoma
  • Also known as paraganglioma
Q28What is Hutchinson sign and what does it imply in this patient?▸
  • Subungual discolouration extending to involve the eponychium
  • Hutchinson sign - treat as melanoma until proven otherwise
Q29What are the classical ABCDE features of melanoma?▸
  • Asymmetry
  • Border
  • Color
  • Diameter (<6mm likely benign)
  • Elevation/enlargement
Q30What are the risk factors for melanoma?▸
  • Fair skin, multiple nevi, family history
  • Sun exposure, immunosuppression
Q31How is melanoma worked up?▸
  • Hx: recent change, itch, bleeding
  • PE: ulceration, satellite lesions, regional lymph nodes
  • Imaging: CT thorax and abdomen to rule out metastasis (lung/liver); USG for lymph nodes
  • Dx: incisional biopsy, LN biopsy
Q32What are the Breslow and Clark classifications of melanoma?▸
  • Breslow: depth in mm - <0.75 / 1.5 / 4 / >4; survival 96% if <0.7mm, 47% if >4mm
  • Clark I: epidermis (in situ), no invasion (normal melanocytes at deepest epidermal layer)
  • Clark II: papillary dermis; III: papillary dermis up to papillary-reticular interface
  • Clark IV: reticular dermis; V: subcutaneous tissue
Q33What determines the treatment of melanoma?▸
  • Depends on grading, lymph nodes, metastasis, location of lesion
  • 1mm -> 1cm resection margin
  • >1mm -> 2cm margin + sentinel LN biopsy (+/- radical LN dissection)
  • Subungual melanoma -> distal amputation + sentinel LN biopsy
  • Positive LN/metastasis: local resection, LN dissection, chemotherapy
  • Poor prognostic factors: depth, male, neck/scalp site, ulceration, LN or metastasis
Q34What is a schwannoma (neurilemma)?▸
  • Encapsulated tumour on the surface of a peripheral nerve
  • Associated with mutation affecting the NF2 gene
Q35What are the clinical and MRI findings in a schwannoma?▸
  • Hx: paraesthesia in the distribution of the peripheral nerve
  • PE: positive Tinel sign
  • MRI: T1 low, T2 high, enhances with contrast; string sign (Ddx: neurofibroma)
Q36What is the histology of a schwannoma?▸
  • Antoni A: spindle cells arranged in intersecting bundles
  • Antoni B: loosely arranged cells
  • Verocay bodies are pathognomonic
  • Uniform S100 antibody staining
Q37What is the treatment of a schwannoma?▸
  • Marginal excision with careful dissection
  • Excise the mass parallel to the nerve